ACE2 is expressed in the lungs (mainly in type 2 alveolar epithelial cells - AT2s) and also in the heart, intestine and kidneys, supporting mechanisms for dysfunction in multiple organs, which has also been observed in COVID-19 patients (Zhang H et al. 2020). This evidence concerns the gene ACE2 and COVID-19.